The Y216-phosphorylated active form of GSK3B is significantly decreased in squamous cell carcinoma [66] and in lung cancer, inhibiting GSK3B increases the expression of the transcriptional repressor Snail, which suppresses E-cadherin and promotes EMT [67]. This evidence concerns the gene GSK3B and lung cancer.